Global Cancer Tumor Profiling Market 2022 by Company, Regions, Type and Application, Forecast to 2028

The Cancer Tumor Profiling market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (researcher) latest study, due to COVID-19 pandemic, the global Cancer Tumor Profiling market size is estimated to be worth US$ 40550 million in 2021 and is forecast to a readjusted size of USD 78790 million by 2028 with a CAGR of 10.0% during review period. Personalized Medicine accounting for % of the Cancer Tumor Profiling global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Next-generation Sequencing (NGS) segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Cancer Tumor Profiling include Qiagen N.V., Roche Molecular Systems Inc., Abott Molecular, Illumina Inc., and NeoGenomics Laboratories, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Cancer Tumor Profiling market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Next-generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Microarray
Others
Market segment by Application, can be divided into
Personalized Medicine
Diagnostics
Biomarker Discovery
Prognostics
Research Applications
Market segment by players, this report covers
Qiagen N.V.
Roche Molecular Systems Inc.
Abott Molecular
Illumina Inc.
NeoGenomics Laboratories
HTG Molecular Diagnostic
Genomic Health Inc.
Hologic Gen-Probe
BD Biosciences
Siemens Healthineers
Claris Life Sciences
Personal Genome Diagnostics, Inc.
Perthera, Inc.
Foundation Medicine, Inc
V., Strand
ApoCell
Contextual Genomics
Agendia
GenScript
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Cancer Tumor Profiling product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Cancer Tumor Profiling, with revenue, gross margin and global market share of Cancer Tumor Profiling from 2019 to 2022.
Chapter 3, the Cancer Tumor Profiling competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Cancer Tumor Profiling market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Cancer Tumor Profiling research findings and conclusion, appendix and data source.